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Abstract:  
Objective: To compare the outcome of four weeks use of High Grade Extract of Chamomile and the placebo on 
sleep diary data. Study Design: Randomized controlled clinical trial. Place and Duration of Study: Gynecology 
outdoor, Nishtar Hospital Multan from January 22, 2018 to January 10, 2019. Methodology: Two equal groups 
were made with 53 menopausal women in each. Age, age at menarche and menopause, and BMI was compared 
between the two groups. Sleep latency, time and number of awakenings, total sleep time, sleep quality, sleep 
efficiency, PQSI score, BDI, FSS and STAI-T score were compared between both the groups at baseline and 28th 
day. Student t-test was applied using SPSS v.23 computer software. P>0.05 was considered statistically 
insignificant. Results: After 4 weeks of treatment, significant improvement was observed in sleep latency, time of 
waking after sleep onset, number of awakenings and total sleep time in the Chamomile group compared with 
placebo group (0.023, 0.002, 0.019 and <0.001, respectively). The improvement in STAI score was statistically 
significant (0.024) in the chamomile group. , There was some improvement observed in the chamomile group in 
terms of sleep quality (0.075) and sleep efficiency (0.059) but the differences were still statistically insignificant. 
Conclusion: It is concluded that chamomile extract has significant beneficial effects on the menopausal women 
suffering from sleep disorders. 
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Introduction: 
Menopause is an age related condition, experienced by all women. Menopause is term which describes those 
changes which a women undergoes just before or after the complete cessation of menstruation. This marks the end 
of reproductive age. When a female is born, there is a finite number of eggs present in the ovary. Hormones which 
are produced by the ovaries are estrogen and progesterone which play an important role in the regulation of 
ovulation and menstruation 1. Menopause occurs when there are no more eggs present in the ovaries to be released 
and menstruation ceases. Normally, menopause occurs after the age of forty years. Earlier menopause also occurs, 
some causes of which are ovarian destruction following chemotherapy, hysterectomy, and premature ovarian 
syndrome and when occurring before the age of forty years, it is termed as premature menopause 2. As the age of 
menopause approaches, most common symptoms experienced by the women are hot flushes, mood swings, fatigue, 
depression, insomnia, irritability and joint and muscle aches 3, 4, 5. 
Many sleep related complaints are associated with menopause. In spite of extensive symptoms, few 
polysomnographic changes have been documented which are associated with menopause. There were no 
significant changes observed in the polysomnograms when the individuals, who were transitioning to menopause, 
were surveyed with polysomnography in the Wisconsin cohort 6, rather an increase in obstructive sleep apnea was 
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observed. Similar pattern s observed in the polysomnograms of young men and women, but increasing age, women 
incline to maintain delta sleep pattern for a longer time as compared the young men. There is worsening of sleep 
efficiency in older menopausal women as compared with the young ovulating women 7, 8. Vasomotor instability is 
the chief problem of menopause in a subset of women which ultimately results in disturbance of sleep. This sleep 
disturbance is nor experience by all the menopausal women. 
One of the most ancient herbs known to mankind is chamomile. Two varieties are known, German chamomile and 
Roman chamomile. A variety of flavonoids and terpenoids are found in the dried leaves of chamomile, due to 
which t is vastly used in the preparation of medicines. Chamomile is commonly used in the form of tea. Most 
common therapeutic uses of chamomile include menstrual irregularities, insomnia, inflammation, hemorrhoids, 
muscle spasms, ulcers and gastrointestinal disorders. Essential oils present in chamomile are an important 
component in cosmetic as well as aromatherapy. Morin et al. 9 observed that almost 15% of the adults use some 
sort of herbal remedies for their sleep disorders compared with 11% who were using prescription medication. 
Sedative effect of chamomile is thought to be caused by apigenin, a flavonoid constituent of chamomile, through 
modification of Gama aminobutyric acid (GABA) receptors 10. In the study by Kupfersztain et al. 11 observed that 
there was a significant alleviation of fatigue and sleep disturbances by twelve weeks use of herbal extract of 
chamomile. Kakuta H et al. 12 revealed that the patients receiving chamomile jelly experienced more relaxation. 
Sleep diaries of young men showed lesser latency in onset of sleep, night time awakenings and morning sleepiness. 
Some studies have been conducted to observe the efficacy of use of chamomile extract in improving the sleep 
disorders and day time functioning capabilities in general population but the data is still lacking. We steered current 
study to detect the effectiveness of four weeks use of high quality chamomile extract in removing the complaints 
of sleep disturbances by the post-menopausal women when compared with the patents who received placebo. 
 
Material and methodology: 
We selected 106 post-menopausal women who presented to the Gynecology outdoor patients department at Nishtar 
Hospital Multan, with any type of sleep disturbance over a time period from January 22, 2018 to January 10, 2019. 
Sample size was calculated by taking the study by Zick SM et al. 13 as reference. Ethical approval was obtained 
from the ethics committee of the respective hospital. All the patients who gave past history of congestive heart 
failure, cancer, asthma, mood or anxiety disorder, obsessive compulsive disorder, lifelong psychotic or bipolar 
disorder, obstructive sleep apnea, substance abuse disorder, restless leg syndrome and known allergy to chamomile 
or other members of ragweed family, were excluded from this study. 
All the patients were explained about the complete procedure and informed consent on written forms was obtained. 
Age of patients, age at menarche and menopause, and body mass index of all the patients was recorded. All the 
patients were asked to complete their sleep diaries on every morning for one whole week prior to the start of the 
trial. After that, all the patients were randomly divided into two groups, one group to receive 30 oral drops mixed 
50 ml of water of high grade extract of chamomile (Plant Therapy German Chamomile), twice daily and the other 
group to receive corresponding dose of the placebo. All the patients were advised to take their medicine, first dose 
after lunch and the second dose one hour before going to bed. Patients were also advised to fill their sleep diaries 
during the fourth week of their treatment. All the patients were called back in the outdoor clinic on the 28th day. 
In the sleep diary, patients were to record bed time, wake up time, latency in sleep onset, time of awakening after 
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the sleep onset, number of awakenings after sleep onset and the quality of sleep. Primary variables which were 
derived from the sleep diary were sleep efficiency (total sleep time / time in bed × 100) and Total sleep time. 
Secondary variables recoded were the common consequence of sleeplessness over day time functioning. For that 
purpose, patients were requested to complete their Beck Depression Inventory (BDI) 14, Fatigue Severity Scale 15 
and State Trait Anxiety Inventory Trait Subscale (STAI-T) 16 along with Pittsburgh Sleep Quality Index (PSQI) 
17, on the baseline visit as well as the 28th day visit. 
Age, age at menarche and menopause, and body mass index was compared between the two groups. Sleep latency, 
time of awakening after sleep, number of awakenings, total sleep time, sleep quality, sleep efficiency, Pittsburgh 
Sleep Quality Index total score, Beck Depression Inventory (BDI), Fatigue Severity Scale (FSS) and State Trait 
Anxiety Inventory Trait Subscale (STAI-T) were compared between both the groups both before and after four 
weeks trial with high quality extract of chamomile and corresponding placebo. As all the data was continuous, so 
Student t-test was applied using SPSS v.23 computer software. P value above 0.05 was considered statistically 
insignificant. 
 
Results: 
We selected one hundred and six menopausal women and assorted them randomly into two groups with same 
number of patients. When matched, both the groups were not significantly different considering the mean age of 
patients, mean age of menarche of patients, mean age of menopause and mean body mass index (p value 0.074, 
0.527, 0.331 and 0.133, respectively). Table-I 
Prior to the start of treatment, sleep latency, time of waking after the onset of sleep, number of awakenings and 
total sleep time were not significantly different (p value 0.536, 0.339, 0.254, and 0.614, respectively). When the 
treatment was continued for at least four weeks and data was recorded again, a significant improvement was 
observed in sleep latency, time of waking after the onset of sleep, number of awakenings and total sleep time in 
the Chamomile group when compared with placebo group (p value 0.023, 0.002, 0.019 and <0.001, respectively). 
Before the treatment, there was no significant difference in the data of sleep quality (p = 0.187), sleep efficiency 
(p = 0.185) and PQSI total score (p = 0.243) between the chamomile and the placebo groups. After a full four 
weeks treatment, there was some improvement observed in the chamomile group in terms of sleep quality (p = 
0.075) and sleep efficiency (p = 0.059) but the difference was still statistically insignificant. There was no 
significant difference in the improvement of PQSI total score by the 4th week of treatment (p=0.675). Table-II 
When the data about the day time functioning was recorded prior to the start of the treatment, the difference in 
fatigue severity scale score and State trait anxiety inventory score was of no statistical significance (p value 0.468 
and 0.465, respectively) but the difference in Beck depression inventory score was significant (p value 0.047). 
After the completion of four week treatment, no significantly different improvement was observed in the 
chamomile group in comparison with the placebo group in terms of fatigue severity scale score (p value 0.242) 
and Beck depression inventory (p value 0.067) but the improvement in State trait anxiety inventory score was 
statistically significant (p value 0.024) in the chamomile group. Table-III 
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Table-I 
Baseline Characteristics 
Variable Placebo (n=53) Chamomile (n=53) p-value 
Age, years 49.66±3.92 51.09±4.25 0.074 
Age at menopause, years 49.79±2.52 49.32±2.45 0.331 
Age at menarche, years 13.77±1.34 13.62±1.09 0.527 
Body mass index, kg/m2 28.07±4.03 29.21±3.66 0.133 
Data is entered as Mean ± S.D 
Table-II 
Sleep Diary Data by the Patients 
 
Variable 
 
Time frame 
Placebo- Group 
(n=53) 
Chamomile-
Group (n=53) 
 
p-value 
Sleep Latency, min Baseline 42.38±17.72 40.38±15.35 0.536 
4th Week 28.49±10.62 24.49±6.85 0.023 
Wake after sleep Onset, min Baseline 37.94±18.39 41.28±17.43 0.339 
4th Week 37.58±8.62 31.87±9.47 0.002 
Awakenings (number) Baseline  1.77±1.01 1.57±0.84 0.254 
4th Week 1.49±0.72 1.15±0.72 0.019 
Total sleep time, hours Baseline 5.26±1.43 5.39±1.17 0.614 
4th Week 5.28±1.09 6.47±1.01 <0.001 
Sleep Efficiency (%) Baseline 75.51±6.92 77.23±6.31 0.185 
4th Week 78.58±6.52 80.89±5.85 0.059 
PQSI Total Score Baseline 9.60±2.06 10.13±2.54 0.243 
4th Week 5.96±1.44 6.07±1.33 0.675 
Data is entered as Mean ± S.D; PQSI= Pittsburgh Sleep Quality Index 
Table-III 
Day Time Functioning Data by the Patients 
 
Variable 
 
Time frame 
Placebo- Group 
(n=53) 
Chamomile-
Group (n=53) 
 
p-value 
FSS Baseline 30.81±12.64 32.42±9.84 0.468 
4th Week 26.68±9.74 24.92±4.80 0.242 
BDI Baseline 9.91±3.24 8.62±3.34 0.047 
4th Week 8.94±3.38 7.79±3.01 0.067 
STAI Trait Subscale Baseline 34.15±9.35 35.45±8.92 0.465 
4th Week 29.06±7.12 26.17±5.74 0.024 
Data is entered as Mean ± S.D; FSS=Fatigue severity scale; BDI= Beck depression 
inventory; STAI= State trait anxiety inventory 
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Discussion: 
In our study we observed that there was a significant improvement in latency of sleep onset, number and duration 
of awakenings after sleep onset and total sleep time after four week use of high quality extract of chamomile. 
There was also betterment in day time performance as there was significant improvement observed in the State 
trait anxiety inventory subscale score. Although no statistically significant, an improvement in sleep quality as 
well as sleep efficiency was observed. Similar results were observed in the study conducted by Zick SM et al. 13 
on the patients suffering from insomnia. In their study, there was significant improvement in sleep efficiency, total 
sleep time, sleep latency, fatigue severity scale score and state trait anxiety inventory subscale score. 
With the increasing age, there is deterioration in the sleep quality and increase in the sleep disturbances in the 
menopausal women in comparison with young ovulating women 7, 8. In a different study, a significant worsening 
of sleep continuity was seen in the women of the age range between forty six to fifty two years 18. There is an 
increase in the occurrence of sleep disorders in the women who are in the transition phase of menopause 19. These 
aberrations in the sleep patterns can be really problematic for some women and day time performance may be 
influenced in a negative way. These all events, in long term, tend to affect the physical as well as mental health of 
women 19. There can be really beneficial effects of chamomile extract usage in such patients. As shown in the 
study by Kakuta H et al. 12, the patients who were taking chamomile jelly experienced additional relaxation. Sleep 
diaries of young males disclosed reduced latency in onset of sleep, night time awakenings and early morning 
sleepiness. Chang SM et al. 20 studied the effects of chamomile tea on the postpartum women who were having 
sleep difficulties. They concluded that it is useful to recommend chamomile tea to the postpartum women as a 
supplement and it can significantly lessen the problems related to quality of sleep and depression. Still there is 
need to conduct more studies to clearly define the effects of chamomile on sleep abnormalities in the menopausal 
women. 
 
Conclusion: 
It is concluded that chamomile extract has significant beneficial effects on the menopausal women suffering from 
sleep disorders. Chamomile extract is related with no observable side effects when used for a short period of time 
but has greater positive effects on sleep quality and efficiency. 
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